BIG
GSK icon

Boothe Investment Group’s GSK GSK Stock Holding History

Boothe Investment Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-18,586
Closed -$653K – 36
2022
Q4 		$653K Hold
18,586
– – 0.63% 29
2022
Q3 		$547K Sell
18,586
-172
-0.9% -$6.52K 0.35% 39
2022
Q2 		$1.03M Sell
18,758
-793
-4% -$43.8K 0.87% 24
2022
Q1 		$1.07M Buy
19,551
+1,738
+10% +$94.4K 0.74% 24
2021
Q4 		$982K Buy
17,813
+360
+2% +$18.7K 0.52% 29
2021
Q3 		$832K Buy
17,453
+306
+2% +$15.4K 0.45% 27
2021
Q2 		$861K Buy
17,147
+1,300
+8% +$62.5K 0.45% 28
2021
Q1 		$707K Buy
+15,847
New +$719K 0.41% 29

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Boothe Investment Group's GSK Position: Q1 2023 in Review

Boothe Investment Group sold out of GSK (GSK) in Q1 2023, closing a stake of 18,586 shares — an estimated $653K sold.

Boothe Investment Group first reported a position in GSK in Q1 2021 and held it in 8 quarters. The position peaked at $1.07M in Q1 2022. 809 funds tracked by Wall St. Rank hold GSK as of Q1 2023.

  • Boothe Investment Group reported no remaining GSK position as of Q1 2023 after selling out during the quarter.
  • Boothe Investment Group sold 18,586 GSK shares in Q1 2023, an estimated $653K.
  • Boothe Investment Group first reported a position in GSK in Q1 2021 and held it in 8 quarters.
  • Boothe Investment Group's GSK position peaked at $1.07M in Q1 2022.
  • 809 funds tracked by Wall St. Rank held GSK as of Q1 2023.

Based on Boothe Investment Group's 13F filing for Q1 2023, filed 13 Apr 2023.